Company Overview
About Revvity
Revvity, Inc. (formerly PerkinElmer) is a global life science tools and diagnostics company, rebranded in 2023 to signal its transformation from a diversified instruments company into a focused provider of solutions for reproductive health, genomics, and applied markets. The company operates in two segments: Life Sciences (analytical instruments, reagents, software for pharmaceutical and academic research) and Diagnostics (immunoassay and molecular diagnostic systems for clinical and screening applications). Revvity is the global leader in newborn screening, processing the tests that check newborns for metabolic and genetic disorders shortly after birth.
Business Model & Competitive Advantage
Revvity reported approximately $2.9 billion in revenue in FY2024, following the divestiture of its Applied, Food, and Enterprise Services segment (sold to New Mountain Capital in 2023 for $2.45 billion) to sharpen focus on higher-growth life science and diagnostics markets. The Diagnostics segment's newborn screening franchise — screening for ~50+ metabolic disorders using Revvity's NeoBase kits and Natus instruments — has near-monopoly characteristics in many countries where national programs are standardized on Revvity platforms. The Life Sciences segment serves pharmaceutical and biotech researchers with automated liquid handling, imaging systems, and genomics tools.
Competitive Landscape 2025–2026
Revvity's strategic priority is integrating its informatics capabilities (Symphony, OneSource laboratory software) with its instrument platforms to create connected lab ecosystems. The company's EUROIMMUN diagnostics business, acquired in 2017 for €1.3 billion, is a leading provider of autoimmune and infectious disease diagnostics in Europe, strengthening its clinical diagnostics presence.
Open Positions
Reddit Discussions
Key Differentiators
Market Leader
Revvity is recognized as a market leader in the Healthcare Tech sector, demonstrating strong industry presence and customer trust.
Enterprise Scale
With $2900M in revenue, Revvity operates at enterprise scale with proven market validation.
Frequently Asked Questions
Not So Random Others
YouShift
YouShift is a United States-based AI healthcare workforce management platform — building the operating system for healthcare staffing starting with AI-powered scheduling agents that replace the comple
Hermes Robotics
Hermes Robotics is an autonomous mobile robot (AMR) and warehouse automation company developing robots and software for logistics and fulfillment operations in warehouses, distribution centers, and ma
Brisk
Brisk is a functional beverage brand offering ready-to-drink iced tea and juice drinks, jointly owned by PepsiCo and Unilever under the Lipton brand partnership. Launched in the 1990s, Brisk positione
Bucket Robotics
Bucket Robotics is an autonomous mobile robot (AMR) company that designs modular, rapidly deployable robots for warehouse automation and industrial material handling. Unlike traditional warehouse auto
Altria
Altria Group, Inc. is a Richmond, Virginia-based tobacco and nicotine company — publicly traded on the New York Stock Exchange (NYSE: MO) as an S&P 500 Consumer Staples component — manufacturing and s
Dusty Robotics
Dusty Robotics is a Mountain View, California-based construction robotics company — backed with $69.5 million in total funding from Root Ventures, Scale Venture Partners, Canaan Partners, GRIDS Capita
Compare Revvity with Competitors
Side-by-side AI visibility scores, platform breakdown, and market position.
Claim This Profile
Are you from Revvity? Claim your profile to see full AI mention excerpts, get weekly visibility change alerts, and optimize how AI systems describe your brand.
Claim Revvity Profile →Track AI Visibility in Real Time
Monitor how ChatGPT, Gemini, Perplexity, and Claude mention Revvity vs competitors. Get alerts when AI recommendations shift.
Start Free Tracking →